Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
To test the safety of Xerese (acyclovir and hydrocortisone)Cream 5%/1% for the treatment of
recurrent cold sores in children ages 6-11yrs after 5 days of treatment.